Erianin inhibited the transcriptional level of PIK3R1 by enhancing the protein level of PPAR, thereby suppressing the PI3K/AKT pathway, which resulted in the suppression of acute myeloid leukemia [46]. This evidence concerns the gene PIK3CA and acute myeloid leukemia.